(Q36230435)

English

Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yuji Toiyama

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Chikao Miki

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yasuhiro Inoue

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Koji Tanaka

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yasuhiko Mohri

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Masato Kusunoki

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

2 December 2010

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Experimental and Therapeutic Medicine

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

95-101

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Risk factors for morbidity and mortality after colectomy for colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

An overview of adjuvant therapy for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Carcinoembryonic antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

1 October 2017

Serum albumin: a prognostic indicator in patients with colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

29 June 2018

A multivariate analysis of pathologic prognostic indicators in large bowel cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

29 June 2018

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

A prospective study of serum C-reactive protein and colorectal cancer risk in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

Deficiency in systemic interleukin-1 receptor antagonist production as an operative risk factor in malnourished elderly patients with colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

Autoreactivity against interleukin 6 as a risk factor in elderly patients with colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

C-reactive protein: a physiological activator of interleukin 6 receptor shedding.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

22 September 2018

Adjuvant chemotherapy for stage II (Dukes» B) colon cancer:too early for routine use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440627

5 December 2018

Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic inflammatory response predicts survival following curative resection of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative and postoperative cytokines in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutritional status and postoperative cytokine response in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of number of nodes retrieved on outcome in patients with rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/ETM.2010.175

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36230435&oldid=1970057849"